Literature DB >> 7539338

Plasma nitrate clearance in mice: modeling of the systemic production of nitrate following the induction of nitric oxide synthesis.

E Veszelovsky1, N H Holford, L L Thomsen, R G Knowles, B C Baguley.   

Abstract

Nitric oxide (NO) is produced in mammals by the enzyme NO synthase (NOS) in response to a number of agents, including the experimental antitumour agent flavone acetic acid (FAA) and the cytokine tumour necrosis factor-alpha (TNF). NO is converted rapidly in the presence of oxygen, water and haemoglobin to oxidation products, largely nitrate. To quantitate the production of nitric oxide it is necessary to know the clearance of nitrate. The concentration of nitrite and nitrate ion in the plasma of C3H and BDF1 (C57BL6 x DBA2) mice was assessed before and after injection of sodium nitrate and sodium nitrite. Nitrite was covered rapidly to nitrate and the kinetics of elimination of nitrate were determined. There was no significant difference between results obtained with different mouse strains, between levels of nitrite and nitrate, or between i.p. and i.v. administration, and the observations were therefore combined. The volume of distribution of nitrate was 0.71 +/- 0.04 l/kg and the clearance was 0.32 +/- 0.02 l/h-1/kg-1 (plasma half-life, 1.54 h). Using previously published data, we developed a pharmacokinetic-pharmacodynamic model that relates the production of TNF in response to administration of FAA, the enhancement of NOS activity in response to TNF, and the elevation of plasma nitrate in response to NO production. This information permits the prediction from observed plasma nitrate values of the amount of NOS induced in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7539338     DOI: 10.1007/bf00689201

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  22 in total

Review 1.  Haem-dependent activation of cytosolic guanylate cyclase by nitric oxide: a widespread signal transduction mechanism.

Authors:  L J Ignarro
Journal:  Biochem Soc Trans       Date:  1992-05       Impact factor: 5.407

2.  Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis.

Authors:  R D Curran; T R Billiar; D J Stuehr; J B Ochoa; B G Harbrecht; S G Flint; R L Simmons
Journal:  Ann Surg       Date:  1990-10       Impact factor: 12.969

3.  Endotoxin and TNF alpha directly stimulate nitric oxide formation in cultured rat hepatocytes from chronically endotoxemic rats.

Authors:  R A Pittner; J A Spitzer
Journal:  Biochem Biophys Res Commun       Date:  1992-05-29       Impact factor: 3.575

4.  Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy.

Authors:  J B Hibbs; C Westenfelder; R Taintor; Z Vavrin; C Kablitz; R L Baranowski; J H Ward; R L Menlove; M P McMurry; J P Kushner
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

5.  Nitric oxide synthase activity in human gynecological cancer.

Authors:  L L Thomsen; F G Lawton; R G Knowles; J E Beesley; V Riveros-Moreno; S Moncada
Journal:  Cancer Res       Date:  1994-03-01       Impact factor: 12.701

6.  Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate.

Authors:  M A Marletta; P S Yoon; R Iyengar; C D Leaf; J S Wishnok
Journal:  Biochemistry       Date:  1988-11-29       Impact factor: 3.162

7.  Plasma pharmacokinetics of the antitumour agents 5,6-dimethylxanthenone-4-acetic acid, xanthenone-4-acetic acid and flavone-8-acetic acid in mice.

Authors:  M J McKeage; P Kestell; W A Denny; B C Baguley
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

8.  Nitric oxide synthesis in endothelial cells: evidence for a pathway inducible by TNF-alpha.

Authors:  S Lamas; T Michel; B M Brenner; P A Marsden
Journal:  Am J Physiol       Date:  1991-10

9.  Increased circulating nitrogen oxides after human tumor immunotherapy: correlation with toxic hemodynamic changes.

Authors:  J B Ochoa; B Curti; A B Peitzman; R L Simmons; T R Billiar; R Hoffman; R Rault; D L Longo; W J Urba; A C Ochoa
Journal:  J Natl Cancer Inst       Date:  1992-06-03       Impact factor: 13.506

10.  Induction of nitric oxide synthase is a necessary precondition for expression of tumor necrosis factor-independent tumoricidal activity by activated macrophages.

Authors:  R Keller; S Bassetti; R Keist; A Mülsch; S Klauser
Journal:  Biochem Biophys Res Commun       Date:  1992-05-15       Impact factor: 3.575

View more
  11 in total

1.  Increase of pro-oxidants with no evidence of lipid peroxidation in exhaled breath condensate after a 10-km race in non-athletes.

Authors:  O F Araneda; R Urbina-Stagno; M Tuesta; D Haichelis; M Alvear; M P Salazar; C García
Journal:  J Physiol Biochem       Date:  2013-08-27       Impact factor: 4.158

2.  Pharmacokinetic/pharmacodynamic modeling of methylprednisolone effects on iNOS mRNA expression and nitric oxide during LPS-induced inflammation in rats.

Authors:  Siddharth Sukumaran; Eve-Irene Lepist; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  Pharm Res       Date:  2012-03-16       Impact factor: 4.200

3.  Pharmacodynamic interactions between recombinant mouse interleukin-10 and prednisolone using a mouse endotoxemia model.

Authors:  Abhijit Chakraborty; Sally Yeung; Nancy A Pyszczynski; William J Jusko
Journal:  J Pharm Sci       Date:  2005-03       Impact factor: 3.534

4.  Contributions of nitric oxide synthases, dietary nitrite/nitrate, and other sources to the formation of NO signaling products.

Authors:  Alexandra B Milsom; Bernadette O Fernandez; Maria F Garcia-Saura; Juan Rodriguez; Martin Feelisch
Journal:  Antioxid Redox Signal       Date:  2012-01-18       Impact factor: 8.401

Review 5.  Temporal aspects of the action of ASA404 (vadimezan; DMXAA).

Authors:  Bruce C Baguley; Dietmar W Siemann
Journal:  Expert Opin Investig Drugs       Date:  2010-11       Impact factor: 6.206

6.  Measurement of nitric oxide release evoked by systemic hypoxia and adenosine from rat skeletal muscle in vivo.

Authors:  Clare J Ray; Janice M Marshall
Journal:  J Physiol       Date:  2005-08-25       Impact factor: 5.182

7.  Adrenomedullin and total nitrite levels in children with Henoch-Schönlein purpura.

Authors:  Ismail Islek; Ayşe Balat; Mustafa Cekmen; Muhittin Yürekli; Ali Muslu; Saime Sahinöz; Ercan Sivasli
Journal:  Pediatr Nephrol       Date:  2003-08-12       Impact factor: 3.714

8.  Adrenomedullin and nitrite levels in children with dilated cardiomyopathy.

Authors:  M Kilinç; A Balat; M Cekmen; M Yürekli; K Yilmaz; S Sahinöz
Journal:  Pediatr Cardiol       Date:  2003-01-15       Impact factor: 1.655

9.  NO3--induced pH changes in mammalian cells. Evidence for an NO3--H+ cotransporter.

Authors:  C W Chow; A Kapus; R Romanek; S Grinstein
Journal:  J Gen Physiol       Date:  1997-08       Impact factor: 4.086

10.  Semi-Mechanism-Based Pharmacodynamic Model for the Anti-Inflammatory Effect of Baicalein in LPS-Stimulated RAW264.7 Macrophages.

Authors:  Li Xiang; Ying-Fan Hu; Jia-Si Wu; Li Wang; Wen-Ge Huang; Chen-Si Xu; Xian-Li Meng; Ping Wang
Journal:  Front Pharmacol       Date:  2018-07-18       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.